Schedule 13G ownership disclosure

ANI Pharmaceuticals Inc

Common Stock, par value $0.0001 per share · CUSIP: 00182C103

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Integrated Core Strategies (US) LLC

    Shares: 53,769.00 · Class: 0.2%

  • Millennium Management LLC

    Shares: 65,245.00 · Class: 0.3%

  • Millennium Group Management LLC

    Shares: 65,245.00 · Class: 0.3%

  • Israel A. Englander

    Shares: 65,245.00 · Class: 0.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-111371
Form type
SCHEDULE 13G/A
Filer
ANI PHARMACEUTICALS INC
CIK
CIK 1023024
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub